Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

47 Downloads (Pure)

Original language	English
Pages (from-to)	2419-2422
Number of pages	4
Journal	Diabetes, Obesity and Metabolism
Volume	25
Issue number	8
DOIs	https://doi.org/10.1111/dom.15110
Publication status	Published - Aug-2023

Access to Document

@article{501ef836aa0f47e5a4ca2a1b07eef88d,

title = "Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan",

author = "Smeijer, {J. David} and Kohan, {Donald E.} and {de Zeeuw}, Dick and Heerspink, {Hiddo J. L.}",

year = "2023",

month = aug,

doi = "10.1111/dom.15110",

language = "English",

volume = "25",

pages = "2419--2422",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley",

number = "8",

}

TY - JOUR

T1 - Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan

AU - Smeijer, J. David

AU - Kohan, Donald E.

AU - de Zeeuw, Dick

AU - Heerspink, Hiddo J. L.

PY - 2023/8

Y1 - 2023/8

U2 - 10.1111/dom.15110

DO - 10.1111/dom.15110

M3 - Letter

SN - 1462-8902

VL - 25

SP - 2419

EP - 2422

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 8

ER -